103 related articles for article (PubMed ID: 17700399)
1. Use of sirolimus-eluting stents for treatment of in-stent restenosis: long-term follow-up.
Brambilla N; Ferrario M; Repetto A; Bramucci E; Angoli L; Canosi U; Rosso R; Ferlini M; Klersy C; Tavazzi L
J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):699-705. PubMed ID: 17700399
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
3. ISR II study: a long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions.
Commeau P; Barragan PT; Roquebert PO; Siméoni JB
Catheter Cardiovasc Interv; 2005 Oct; 66(2):158-62. PubMed ID: 16158397
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus-eluting stents for the treatment of bare-metal in-stent restenosis: long-term clinical follow up.
Sheiban I; Chiribiri A; Beninati S; Moretti C; Omede P; Sciuto F; Marra WG; Biondi-Zoccai G; Bollati M; Gambino A; Trevi GP
J Invasive Cardiol; 2007 Apr; 19(4):174-80. PubMed ID: 17404403
[TBL] [Abstract][Full Text] [Related]
6. [Two-year clinical follow-up in 200 patients receiving sirolimus-eluting stents in lesions at a high risk of restenosis].
de la Torre-Hernández JM; Sainz-Laso F; Llano-Cardenal M; Ruiz-Lera M; Fernández-Friera L; Burgos V; Zueco J; Figueroa A; Colman T
Rev Esp Cardiol; 2006 Mar; 59(3):225-31. PubMed ID: 16712746
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
[TBL] [Abstract][Full Text] [Related]
8. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.
Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R
J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus-eluting stents for the treatment of in-stent restenosis.
Degertekin M; Saia F; Lemos PA; Arampatzis CA; Serruys PW
Minerva Cardioangiol; 2003 Oct; 51(5):475-84. PubMed ID: 14551517
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes after bioabsorbable polymer- and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database.
Liu HB; Xu B; Yang YJ; Wang Y; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Ma WH; Li JJ; Qiao SB; Chen JL; Li W; Gao RL
Chin Med J (Engl); 2009 Mar; 122(6):681-6. PubMed ID: 19323934
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis.
Saia F; Lemos PA; Hoye A; Sianos G; Arampatzis CA; de Feyter PJ; van der Giessen WJ; Smits PC; van Domburg RT; Serruys PW
Catheter Cardiovasc Interv; 2004 Jul; 62(3):283-8. PubMed ID: 15224289
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
[TBL] [Abstract][Full Text] [Related]
16. Procedural and long-term results of sirolimus-eluting stent in patients at high risk for restenosis.
Presbitero P; Zavalloni D; Scatturin M; Marisco F; Pagnotta P; Boccuzzi G
Minerva Cardioangiol; 2004 Jun; 52(3):189-94. PubMed ID: 15194980
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E
J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement.
Neumann FJ; Desmet W; Grube E; Brachmann J; Presbitero P; Rubartelli P; Mügge A; Di Pede F; Füllgraf D; Aengevaeren W; Spedicato L; Popma JJ
Circulation; 2005 Apr; 111(16):2107-11. PubMed ID: 15851617
[TBL] [Abstract][Full Text] [Related]
19. The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis.
Habara S; Mitsudo K; Goto T; Kadota K; Fujii S; Yamamoto H; Kato H; Takenaka S; Fuku Y; Hosogi S; Hirono A; Yamamoto K; Tanaka H; Hasegawa D; Nakamura Y; Tasaka H; Otsuru S; Okamoto Y; Yamada C; Miyamoto M; Inoue K
Heart; 2008 Sep; 94(9):1162-5. PubMed ID: 18032460
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
Minutello RM; Bhagan S; Sharma A; Slotwiner AJ; Feldman DN; Cuomo LJ; Wong SC
J Interv Cardiol; 2007 Dec; 20(6):458-65. PubMed ID: 18042050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
